JP2014512367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014512367A5 JP2014512367A5 JP2014504443A JP2014504443A JP2014512367A5 JP 2014512367 A5 JP2014512367 A5 JP 2014512367A5 JP 2014504443 A JP2014504443 A JP 2014504443A JP 2014504443 A JP2014504443 A JP 2014504443A JP 2014512367 A5 JP2014512367 A5 JP 2014512367A5
- Authority
- JP
- Japan
- Prior art keywords
- support
- covalent
- polystyrene
- specific
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004793 Polystyrene Substances 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical class OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 244000126010 Pithecellobium dulce Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305451.4 | 2011-04-15 | ||
| EP11305451A EP2511295A1 (en) | 2011-04-15 | 2011-04-15 | Compositions for preventing and/or treating an infection by an HIV-1 virus |
| PCT/IB2012/051842 WO2012140620A1 (en) | 2011-04-15 | 2012-04-13 | Compositions for preventing and/or treating an infection by an hiv-1 virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014512367A JP2014512367A (ja) | 2014-05-22 |
| JP2014512367A5 true JP2014512367A5 (enExample) | 2015-04-23 |
| JP6027094B2 JP6027094B2 (ja) | 2016-11-16 |
Family
ID=44721142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014504443A Active JP6027094B2 (ja) | 2011-04-15 | 2012-04-13 | Ｈｉｖ−１ウイルスによる感染を予防及び／又は治療するための組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9181299B2 (enExample) |
| EP (2) | EP2511295A1 (enExample) |
| JP (1) | JP6027094B2 (enExample) |
| CN (1) | CN103687875B (enExample) |
| BR (1) | BR112013026150B1 (enExample) |
| CA (1) | CA2831258C (enExample) |
| ES (1) | ES2912099T3 (enExample) |
| RU (1) | RU2603262C2 (enExample) |
| UA (1) | UA112863C2 (enExample) |
| WO (1) | WO2012140620A1 (enExample) |
| ZA (1) | ZA201307019B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016184963A1 (en) | 2015-05-19 | 2016-11-24 | Innavirvax | Treatment of hiv-infected individuals |
| WO2016184962A1 (en) | 2015-05-19 | 2016-11-24 | Innavirvax | Treatment of hiv-infected individuals |
| US11680086B2 (en) * | 2017-04-18 | 2023-06-20 | Shanxi Kangbao Biological Product Co., Ltd. | Lipopeptide for potently inhibiting HIV, derivative thereof, pharmaceutical composition thereof and use thereof |
| EP4115900A1 (en) * | 2021-07-05 | 2023-01-11 | Diaccurate | Novel antigens and vaccines |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
| EP0378881B1 (en) | 1989-01-17 | 1993-06-09 | ENIRICERCHE S.p.A. | Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines |
| IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| EP1162999B1 (en) | 1999-03-19 | 2006-11-29 | Glaxosmithkline Biologicals S.A. | Vaccine against Streptococcus pneumoniae |
| JP2002541808A (ja) | 1999-04-09 | 2002-12-10 | テクラブ， インコーポレイテッド | ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US6399067B1 (en) * | 2000-04-28 | 2002-06-04 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
| WO2002066504A2 (en) * | 2001-02-16 | 2002-08-29 | Hybrigenics | Protein-protein interactions in saccharomyces cerevisiae |
| FR2851165A1 (fr) * | 2003-02-19 | 2004-08-20 | Aventis Pasteur | Antigene derivant de l'helice c de la proteine gp41 |
| US8088976B2 (en) * | 2005-02-24 | 2012-01-03 | Monsanto Technology Llc | Methods for genetic control of plant pest infestation and compositions thereof |
| US8961987B2 (en) * | 2007-08-20 | 2015-02-24 | New York University | Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies |
| CN104232679A (zh) * | 2009-01-28 | 2014-12-24 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物及其制备方法 |
| BRPI1008721A2 (pt) * | 2009-02-06 | 2016-03-08 | Inserm Inst Nat De La Santé Et De La Rech Médicale | métodos para tratamento terapêutico ou profiláctico de hiv, método profilático, composição terapêutica ou preparação, associação de vacina terapêutica, kit para implantação de método terapêutico |
| US20120164670A1 (en) * | 2009-06-23 | 2012-06-28 | President And Fellows Of Harvard College | Methods and kits for measuring enzyme activity |
-
2011
- 2011-04-15 EP EP11305451A patent/EP2511295A1/en not_active Withdrawn
-
2012
- 2012-04-13 JP JP2014504443A patent/JP6027094B2/ja active Active
- 2012-04-13 CN CN201280018349.7A patent/CN103687875B/zh active Active
- 2012-04-13 CA CA2831258A patent/CA2831258C/en active Active
- 2012-04-13 EP EP12718402.6A patent/EP2697259B1/en active Active
- 2012-04-13 ES ES12718402T patent/ES2912099T3/es active Active
- 2012-04-13 RU RU2013145467/10A patent/RU2603262C2/ru active
- 2012-04-13 WO PCT/IB2012/051842 patent/WO2012140620A1/en not_active Ceased
- 2012-04-13 UA UAA201311896A patent/UA112863C2/uk unknown
- 2012-04-13 US US14/111,790 patent/US9181299B2/en active Active
- 2012-04-13 BR BR112013026150-1A patent/BR112013026150B1/pt active IP Right Grant
-
2013
- 2013-09-18 ZA ZA2013/07019A patent/ZA201307019B/en unknown
-
2015
- 2015-09-30 US US14/870,287 patent/US9802983B2/en active Active
-
2017
- 2017-09-22 US US15/712,195 patent/US10174080B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hage et al. | Affinity chromatography: a historical perspective | |
| JP2014501758A5 (enExample) | ||
| JP2019513784A5 (enExample) | ||
| JP2014512367A5 (enExample) | ||
| JP2017514481A5 (enExample) | ||
| JP2006502416A5 (enExample) | ||
| RU2012115491A (ru) | Способ идентификации гетеромультимерных модифицированных убиквитиновых белков со способностью связываться с лигандами | |
| JP2012515160A5 (enExample) | ||
| Zhang et al. | Novel magnetic bovine serum albumin imprinted polymers with a matrix of carbon nanotubes, and their application to protein separation | |
| BRPI0519399A2 (pt) | material de suporte sàlido e mÉtodo para isolamento de anticorpos ou derivados destes | |
| HRP20221390T1 (hr) | Analiza za antitijela jc virusa | |
| JP2021500551A5 (enExample) | ||
| HRP20230186T1 (hr) | METODA PROCJENE RIZIKA OD PML-a | |
| JP2013507237A5 (enExample) | ||
| RU2015154792A (ru) | Выделенный антиген лейкоцидина Staphylococcus aureus, антитело, специфически связывающееся с субъединицей LukGH и способ определения связывания или токсичности двухкомпонентного цитолизина LukGH Staphylococcus aureus | |
| JP2018534568A5 (enExample) | ||
| Park et al. | Design of bio-inspired silica-encapsulated protein A for improved immunoprecipitation assays | |
| JP2015515969A5 (enExample) | ||
| CN104650185B (zh) | 一条与猪瘟e0蛋白相结合的多肽序列及其应用 | |
| Ning et al. | Rapid protein digestion and purification with membranes attached to pipet tips | |
| GB201100515D0 (en) | Methods of capturing bindable targets from liquids | |
| Kumada et al. | High biological activity of a recombinant protein immobilized onto polystyrene | |
| KR101293666B1 (ko) | 단백질 나노입자를 이용한 3차원 나노구조체 | |
| Li et al. | Cupric ion enhanced molecular imprinting of bovine serum albumin in hydrogel | |
| JPWO2010050439A1 (ja) | タンパク質固定化用担体およびその利用 |